Filing Details

Accession Number:
0001628280-22-025100
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-19 08:37:26
Reporting Period:
2022-09-15
Accepted Time:
2022-09-19 08:37:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1213037 Cardiff Oncology Inc. CRDF () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184778 W Gary Pace C/O Cardiff Oncology, Inc.
11055 Flintkote Avenue
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-15 150,000 $1.71 644,811 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.65 to $1.78. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request.